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Four new oleanane saponins (1-4), together with three known saponins, were isolated from the aerial parts of Dizygotheca elegantissima R. Vig. & Guillaumin. 
Their structures were elucidated by 1D and 2D NMR experiments including 1D TOCSY, DQF-COSY, HSQC, and HMBC spectroscopy, as well as ESIMS 
analysis. The antiproliferative activity of all isolated compounds was evaluated.
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In our ongoing search for new bioactive compounds from plants 
belonging to the family Araliaceae growing at the Botanical Garden 
of Palermo [1-3], we have performed a phytochemical study of the 
aerial parts of Dizygotheca elegantissima R. Vig. & Guillaumin [4]. 
Plants of the family Araliaceae have been used in Asian countries as 
folk remedies for treatment of pain, rheumatic arthritis, fracture, 
sprains, and lumbago [5,6]. Four new oleanane saponins (1-4) were 
isolated from D. elegantissima, along with three known saponins. 
Taking into account the fact that some triterpene saponins have 
been found to possess cytotoxic activity against various tumor cell 
lines [2,7], the antiproliferative activity of 1-7 was evaluated [8]. 
Compound 1 was assigned the molecular formula C48H78O17, as 
determined by 13C, 13C DEPT NMR, and positive HRESIMS (m/z
927.5311 [M + H]+). The ESIMS of 1 showed a [M + H]+ ion at m/z
927 and prominent fragments at m/z 781 [M - 146 + H]+ and 765 [M 
- 162 + H]+, due to the loss of one deoxyhexose and one hexose 
units, respectively, and m/z 457 [M – (162 + 162 + 146) + H]+, due 
to the loss of one deoxyhexose and two hexose units. A peak at m/z
457 was attributed to the aglycone moiety. Data from the 13C NMR 
spectrum (see Experimental Section and Table 1) suggested a 
triterpenoid glycoside structure. The 1H NMR spectrum of the 
aglycone portion of 1 showed signals for seven tertiary methyl 
groups (į 0.81, 0.86, 0.95, 0.97, 1.05, 1.10, 1.24), a typical signal of 
H-3ax at į 3.22 (dd, J=12.0, 4.5 Hz), and a characteristic olefinic 
proton at į 5.33 (t, J=3.5 Hz). The 13C NMR spectrum showed for 
the aglycone moiety 30 signals that could be correlated 
unambiguously to the corresponding proton chemical shifts from 
the HSQC experiment, leading to the identification of the aglycone 
as oleanolic acid [3]. 
The sugar portion of 1 exhibited, in the 1H NMR spectrum (Table 
2), three anomeric proton signal resonances (į 5.90, d, J = 1.8 Hz; 
4.50, d, J = 7.8 Hz; 4.35, d, J = 8.0 Hz) and one methyl doublet     
(į 1.28, d, J = 6.5 Hz). The 1D TOCSY and 2D NMR experiments 








 R R1 R2
1 Glc-(1o2)-Glc H H 
2 Glc-(1o2)-Glc H Ac 
3 Glc-(1o6)-Glc-(1o2)-Xyl H H 
4 Glc-(1o6)-Glc-(1o2)-Xyl OH H 
moieties were present (Tables 1 and 2). The configurations of the 
sugar units were assigned after hydrolysis of 1 with 1N HCl. The 
hydrolysate was trimethylsilated, and GC retention times of each 
sugar were compared with those of authentic sugar samples 
prepared in the same manner [7]. The absence of any 13C NMR 
glycosidation shift for the Į-L-rhamnopyranosyl, and one of the ȕ-
D-glucopyranosyl moieties indicated that these sugars were terminal 
units. Glycosidation shift was observed for C-2glc (į 83.5). The 
chemical shifts of H-1rha (į 5.90) and C-1rha (į 94.0) indicated that 
the Į-L-rhamnopyranosyl unit was involved in an ester linkage with 
the C-28 carboxylic group. Thus, compound 1 was identified as 3ȕ-
O-[ȕ-D-glucopyranosyl-(1o2)-ȕ-D-glucopyranosyl]-olean-12-en-
28-O-[Į-L-rhamnopyranosyl] ester.
Compound 2 was assigned the molecular formula C50H80O18, as 
shown by its HRESIMS data (m/z 969.5415 [M + H]
+
), in 
combination with the 13C NMR spectrum. The 13C and 13C DEPT 
spectra (Table 1) showed 50 signals, of which 30 were assigned to 
the aglycone, 18 to the sugar, and two to an acetyl group. 1D 
TOCSY, DQFCOSY, and HSQC NMR experiments showed the 
presence of two ȕ-D-glucopyranosyl and one Į-L-rhamnopyranosyl 
unit (Tables 1 and 2). The HSQC spectrum also showed 
glycosylation shifts for C-2 (į 84.0) of one glucopyranosyl unit and 
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Table 1: 13C NMR data for glycosyl moieties of compounds 1 - 3 (CD3OD, 600 MHz)
a.
1 2 3 
position įC įC įC
Rha-1 94.0 94.3  
2 71.0 69.5  
3 73.2 74.6  
4 72.2 71.0  
5 72.0 72.4  
6 18.3 18.0  
Xyl 1   105.0 
2   81.6 
3   77.8 
4   70.4 
5   66.0 
6    
GlcI 1 104.5 104.7 103.9 
2 83.5 84.0 74.7 
3 77.0 76.8 77.8 
4 71.0 71.0 70.9 
5 77.8 78.0 76.7 
6 62.3 62.5 69.4 
GlcII 1 103.7 103.6 103.3 
2 74.9 75.0 75.0 
3 77.8 77.8 77.9 
4 71.2 71.3 71.4 
5 78.0 78.0 78.0 
6 62.6 62.6 62.4 
CH3CO  21.0  
CH3CO  172.8  
a chemical shifts in ppm; assignments confirmed by COSY, TOCSY, HSQC, and 
HMBC experiments. 
acylation shifts for H-3 (į 5.05) and C-3 (į 74.6) of the 
rhamnopyranosyl unit. The acyl moiety was identified as an acetyl 
group from the NMR data [9]. An unambiguous determination of 
the sequence and linkage sites was obtained from HMBC 
correlations. The configurations of the sugar units were assigned as 
for compound 1. In this way, those of 2 were determined to be       
D-glucose and L-rhamnose in the ratio 2:1. On the basis of this 
evidence, 2 was established as the new compound 3ȕ-O-[ȕ-D-
glucopyranosyl-(1o2)-ȕ-D-glucopyranosyl]-olean-12-en-28-O-[(3-
O-acetyl)-Į-L-rhamnopyranosyl] ester. 
Compound 3 was obtained as an amorphous powder with the 
molecular formula C53H86O21, as deduced by HRESIMS (m/z
1059.5746 [M + H]
+
) and confirmed by 13C NMR and 13C DEPT 
data. The MS/MS spectrum of compound 3 showed prominent 
fragments at m/z 735 [M - (162 + 162) + H)]+, and 589 [M - (162 + 
162 + 146) + H)]+.
The spectroscopic data of the aglycone moiety of 3 were identical to 
those of 1. Analysis of sugar chains NMR data (Tables 1 and 2) of 
compound 3 and comparison with those of 1, revealed 3 to differ 
from 1 only in the sugar chain at C-3. The sugar portion at C-3 of 3
exhibited three anomeric proton resonances (į 4.56, d, J = 7.8 Hz; 
4.40, d, J = 7.5 Hz; 4.36, d, J = 8.0 Hz) in the 1H NMR spectrum 
(Table 2). The 1D TOCSY and 2D NMR experiments indicated that 
two ȕ-glucopyranose, and one ȕ-xylopyranose moieties were 
present (Tables 1 and 2). The absence of any 13C NMR 
glycosidation shift for one of the ȕ-glucopyranosyl moieties 
indicated that this sugar was a terminal unit. Glycosidation shifts 
were observed for C-6glc (į 69.0), and C-2xyl (į81.6) (Table 1). 
Direct evidence for the sugar sequence and linkage site to the 
aglycone was derived from the HMBC experiment that showed 
unequivocal correlations between resonances at į4.40 and į91.8 
(H-1xyl—C-3), indicating that xylose was linked to C-3 of the 









1 2 3 
position įH įH įH
Rha-1 5.90 d (1.8) 5.88 d (1.5) 5.88 d (1.8) 
2 3.78 dd  (2.5, 1.8) 3.90 dd  (3.0, 1.5) 3.75 dd  (2.5, 1.8) 
3 3.48 dd (9.0, 2.5) 5.05 dd  (9.0, 3.0) 3.46 dd (9.0, 2.5) 
4 3.71 t (9.o) 3.72 t (9.0) 3.70 t (9.0) 
5 3.60 m 3.80 m 3.60 m 
6 1.28 d (6.5) 1.30 d (6.0,) 1.27 d (6.5) 
Xyl 1   4.40 d (7.5) 
2   3.56 dd  (9.0, 7.5) 
3   3.57 t (9.0) 
4   3.62 m 
5a   3.90 dd (11.0, 2.5) 
5b   3.30 dd (11.0, 5.0) 
GlcI 1 4.50 d (7.8) 4.48 d (7.8) 4.56 d (7.8) 
2 3.54 dd  (9.5, 7.8) 3.56 dd  (9.5, 7.8) 3.46 dd  (9.5, 7.8) 
3 3.63 t  (9.5) 3.64 t  (9.5) 3.42 t  (9.5) 
4 3.60 t (9.5) 3.62 t (9.5) 3.36 t (9.5) 
5 3.41 m 3.43 m 3.39 m 
6a 3.64 dd (12.0, 5.0) 3.68 dd (12.0, 5.0) 3.85 dd (12.0, 5.0) 
6b 3.89 dd (12.0, 3.0) 3.92 dd (12.0, 3.0) 4.18 dd (12.0, 3.0) 
GlcII 1 4.35 d (8.0) 4.32 d (8.0) 4.36 d (8.0) 
2 3.40 dd  (9.5, 8.0) 3.38 dd  (9.0, 8.0) 3.32 dd  (9.0, 8.0) 
3 3.37 t  (9.5) 3.35 t  (9.0) 3.35 t  (9.0) 
4 3.39 t (9.5) 3.39 t (9.0) 3.38 t (9.0) 
5 3.47 m 3.42 m 3.40 m 
6a 3.69 dd (12.0, 5.0) 3.66 dd (12.0, 5.0) 3.66 dd (12.0, 5.0) 
6b 3.88 dd (12.0, 3.0) 3.88 dd (12.0, 2.5) 3.88 dd (12.0,2.5) 
CH3CO  2.02 (s)  
a J values are in parentheses and reported in Hz; chemical shifts are given in ppm); 
assignments  were confirmed by COSY, TOCSY, HSQC, and HMBC experiments. 
Comparison of the NMR spectral data of compound 4 (molecular 
formula C53H86O22) with those of 3 showed these compounds to be 
identical in the sugar portion, but different in their aglycones. The 
13C NMR spectra showed, for the aglycone moiety, signals          
that could be unambiguously correlated to the corresponding  
proton chemical shifts from the HSQC experiment, leading             
to the identification of the aglycone as hederagenin [10]. Thus,        
4 was determined to be 3ȕ-O-[ȕ-D-glucopyranosyl-(1o6)-ȕ-D-
glucopyranosyl-(1o2)-ȕ-D-xylopyranosyl]-hederagenin-28-O-[Į-L-
rhamnopyranosyl] ester.  
The three known triterpene glycosides were identified by detailed 
NMR and MS analyses and comparison with literature data as      
3ȕ-O-[ȕ-D-galactopyranosyl-(1o3)-ȕ-D-glucopyranosyl-(1o2)-Į-
L-arabino-pyranosyl oleanolic acid 28-O-Į-L-rhamnopyranosyl-
(1o4)-ȕ-D-glucopyranosyl-(1o6)-ȕ-D-glucopyranoside [11]; 3-O-
ȕ-D-galactopyranosyl-(1o2)-Į-L-arabinopyranosyl-(1o3)-Į-L-rha-
mnopyranosyl-(1o2)-Į-L-rhamnopyranosyl oleanolic acid 28-O-Į-
L-arabinopyranosyl-(1o2)-Į-L-rhamnopyranoside [11], and 3ȕ-O-
Į-L-arabinopyranosyl-olean-12-en-28-O-[ȕ-D-glucopyranosyl-(1o
6)-ȕ-D-glucopyranosyl] ester [12]. 
In the framework of a research project aimed at searching for 
cytotoxic triterpene saponins from medicinal plants, all compounds 
isolated from D. elegantissima were assayed against human uterine 
cervical adenocarcinoma (HeLa), human lymphocyte cells T 
(Jurkat), and human breast adenocarcinoma (MCF7) cell lines. All 
compounds showed an IC50 higher than 50 ȝM [13,14]. 
Experimental 
General experimental procedures: Optical rotations were measured 
on a Perkin-Elmer 241 polarimeter equipped with a sodium lamp 
(589 nm) and a 1 dm microcell. UV spectra were recorded on a 
Perkin-Elmer-Lambda spectrophotometer. NMR experiments were 
performed on a Bruker DRX-600 spectrometer at 300 K. All the 2D 
NMR spectra were acquired in CD3OD or CDCl3 in the phase-
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sensitive mode with the transmitter set at the solvent resonance and 
TPPI (Time Proportional Phase Increment) used to achieve 
frequency discrimination in the Z1 dimension. Standard pulse 
sequences and phase cycling were used for DQF-COSY, TOCSY, 
HSQC, and HMBC experiments. NMR data were processed on a 
Silicon Graphics Indigo2 Workstation using UXNMR software. 
HRESIMS were acquired in positive ion mode on a Q-TOF premier 
spectrometer equipped with an electrospray ion source (Waters-
Milford, MA, USA). Column chromatography was performed over 
Sephadex LH-20. HPLC separations were conducted on a  
Shimadzu LC-8A series pumping system equipped with a Shimadzu 
RID-10A refractive index detector and Shimadzu injector on a C18
P-Bondapak column (30 cm x 7.8 mm, 10 µm Waters, flow rate 2.0 
ml min-1). GC analyses were performed using a Dani GC 1000 
instrument on a l-CP-Chirasil-Val column (0.32 mm x 25 m).
Plant material: The aerial parts of D. elegantissima (Veitch ex 
Mast.) R. Vig. & Guillaumin were collected in Palermo, Italy, 
during May 2007 and were identified by Prof. Giuseppe Venturella 
of the Dipartimento di Scienze Botaniche, University of Palermo, 
Italy, where a voucher specimen is deposited.
Extraction and isolation: The dried powdered D. elegantissima 
aerial parts (300 g) were defatted with n-hexane, and then extracted 
with MeOH to give 13.4 g of extract. The MeOH extract was 
partitioned between n-BuOH and AcOEt, to afford n-BuOH soluble 
(4 g) and AcOEt portions (5.4 g). A portion of the n-BuOH residue 
(2.5 g) was separated on a Sephadex LH-20 column, using MeOH 
as eluent. Fractions were collected, analyzed by TLC (silica 60 F254
gel-coated glass sheets) with n-BuOH-HOAc-H2O (60:15:25) or 
CHCl3-MeOH-H2O (40:9:1), and grouped to obtain 8 fractions     
(1-8). Fraction 2 (245 mg) was chromatographed using                
RP-HPLC (MeOH-H2O (7:3)) to yield 3ȕ-O-[ȕ-D-galactopyranosyl-
(1o3)-ȕ-D-glucopyranosyl-(1o2)-Į-L-arabino-pyranosyl oleanolic 
acid 28-O-Į-L-rhamnopyranosyl-(1o4)-ȕ-D-glucopyranosyl-
(1o6)-ȕ-D-glucopyranoside (8 mg), and 3-O-ȕ-D-galactopyranosyl-
(1o2)-Į-L-arabinopyranosyl-(1o3)-Į-L-rhamno-pyranosyl-(1o2)-
Į-L-rhamnopyranosyl oleanolic acid 28-O-Į-L-arabinopyranosyl-
(1o2)-Į-L-rhamnopyranoside (2.8 mg). Fraction 3 (203 mg) was 
chromatographed using RP-HPLC with MeOH-H2O (7:3) to yield 
compounds 3 (8 mg), 4 (11 mg), and 1 (7 mg). Fractions 4 (120 mg) 
and 5 (30 mg) were subjected to RP-HPLC with MeOH-H2O (7:3) 
to yield compounds 1 (6.5 mg) and 2 (3 mg) from fraction 4, and 1
(4 mg), and 3ȕ-O-Į-L-arabinopyranosyl-olean-12-en-28-O-[ȕ-D-





[Į]D: +37.4 (c 1.00, MeOH). 
1H NMR data of the aglycone (600 MHz, CD3OD): 0.81 (3H, s, 
Me-26), 0.86 (3H, s, Me-24), 0.95 (3H, s, Me-29), 0.97 (3H, s,   
Me-25), 1.05 (3H, s, Me-30), 1.10 (3H, s, Me-23), 1.24 (3H, s,   
Me-27), 2.96 (1H, dd, J = 12.0, 5.0 Hz, H-18), 3.22 (1H, dd,           
J = 12.0, 4.5 Hz, H-3), 5.35 (1H, t, J = 3.5 Hz, H-12). 
13C NMR data of the aglycone (150 MHz, CD3OD) į: 16.0 (C-25), 
16.5 (C-24), 18.0 (C-26), 19.5 (C-6), 23.5 (C-16), 23.8 (C-30), 24.6 
(C-11), 26.2 (C-27), 26.6 (C-2), 28.0 (C-23), 28.2 (C- 15), 30.8   
(C-20), 33.4 (C-29), 33.7 (C-7), 34.0 (C-22), 34.5 (C-21), 37.7    
(C-10), 39.0 (C-4), 39.9 (C-1), 40.3 (C-8), 42.3 (C-14), 42.8 (C-18), 
46.7 (C-19), 47.0 (C-17), 48.8 (C-9), 57.0 (C-5), 90.8 (C-3), 124.3 
(C-12), 144.2 (C-13), 177.8 (C-28). 
1H and 13C NMR of the sugar moiety, see Tables 1 and 2. 
ESIMS m/z 927 [M + H]+, 765 [M - 162 + H]+, 781 [M – 146 + H]+,
619 [M – (162 + 146) + H]+, 457 [M – (162 + 162 + 146) + H]+.




[Į]D: +35.2 (c 1.00, MeOH). 
NMR data of the aglycone see compound 1.
1H NMR and 13C NMR sugar moiety: Tables 1 and 2. 
ESIMS: m/z 969 [M + H]+, 781 [M – (146 – 42) + H]+, 645 [M – 
(162 + 162) + H]+.





[Į]D: +40 (c 1.00, MeOH) 
NMR data of the aglycone see compound 1.
1H NMR and 13C NMR of sugar moiety: Tables 1 and 2. 
ESIMS: m/z 1059 [M + H]+, 735 [M - (162 + 162) + H]+, 589 [M - 
(162 + 162 + 146) + H]+.






[Į]D: +39.4 (c 1.00, MeOH). 
1H NMR data of the aglycone (600 MHz, CD3OD): 0.75 (3H, s, 
Me-23), 0.83 (3H, s, Me-25), 0.94 (3H, s, Me-29), 0.96 (3H, s, Me-
30), 1.00 (3H, s, Me-26), 1.18 (3H, s, Me-27), 2.27 (1H, d, J = 12.8, 
Hz, H-18), 3.62 (1H, dd, J = 12.0, 4.5 Hz, H-3); 3.32 (1H, d, J = 
12.4 Hz, H-23a), 3.63(1H, d, J =12.4 Hz, H-23b), 5.28 (1H, t, J = 
3.2 Hz, H-12).
13C NMR data of the aglycone (150 MHz, CD3OD) į: 13.0 (C-24), 
18.0 (C-26), 18.2 (C-6), 18.5 (C-25), 24.0 (C-11), 24.5 (C-30), 
24.7(C-16), 25.5 (C-2), 26.0 (C-27), 28.0 (C-15), 31.3 (C-20), 32.5
(C-7), 33. 5 (C-29), 33.5 (C-22), 34.0 (C-21), 37.9 (C-10), 39.5   
(C-1), 42.5 (C-18), 43.0 (C-4), 41.0 (C-8), 47.0 (C-19), 47.6 (C-17),
48.0 (C-5), 43.2 (C-14), 48.2 (C-9), 48.5 (C-5), 87.1 (C-3), 64.4 
(C-23), 124.0 (C-12), 144.3 (C-13), 178.3 (C-28).
1H and 13C NMR of the sugar moiety, see compound 3.
ESIMS: m/z 1075 [M + H]+, 751 [M - (162 + 162) + H]+, 605 [M - 
(162 + 162 + 146) + H]+.
HRESIMS m/z 1075.5733 [M + H]+ (calcd for C53H86O22,
1075.5740).
Cell culture and cytotoxic assay: HeLa (human cervical 
carcinoma), Jurkat (human lymphocyte cells T), and human breast 
adenocarcinoma (MCF7) cell lines were obtained from American 
Type Cell Culture (ATCC) (Rockville, MD, USA). Cells were 
maintained in DMEM and/or RPMI 1640, supplemented with 10% 
FBS, 100 mg/L streptomycin, and 100 IU/mL penicillin (GIBCO) at 
37°C in a humidified atmosphere of 5% CO2. To ensure logarithmic 
growth, cells were subcultured every 2 days. Stock solutions (1 
mg/ml) of all compounds were prepared in DMSO and stored at 
4°C. In all experiments, the final concentration of DMSO did not 
exceed 0.3%, v/v. Cells were seeded in 96-well plates (1 x 
104/well). One day after seeding, cells were exposed to either 
increasing concentrations of each compound or vehicle only and 
incubated for the established times. The number of HeLa, Jurkat 
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and MCF7 viable cells was quantified by MTT assay [8,13] and 
CellTiter-Blue1 Cell Viability assay (Promega). Appropriate 
controls were included in preliminary experiments to exclude any 
interferences of each compound with the assays. The IC50 values 
were obtained from dose-response curves.  
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